Among the most significantly downregulated genes in patients with NAFLD and cirrhosis was the MET proto-oncogene, a receptor tyrosine kinase with Hepatocyte Growth Factor (HGF) as ligand that is important for cellular survival and cellular migration, as well as invasion. This evidence concerns the gene MET and Cirrhosis.